Mereo Biopharma Group (MREO) Income Statement (2023 - 2026)
Income Statement report data from Mar 31, 2023 to Mar 31, 2026 for Mereo Biopharma Group (MREO).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||
Total Revenue | - | - | - | 500K | - | - | - | - | - | 1.00M | - | 9.00M | - |
Operating Expenses | |||||||||||||
Research And Development | 4.75M (+13.37%) | 4.19M (-1.87%) | 4.27M (-20.48%) | 5.37M (+36.64%) | 3.93M (-55.44%) | 8.82M (+178.23%) | 3.17M (-35.96%) | 4.95M (+24.06%) | 3.99M (-17.05%) | 4.81M (+33.98%) | 3.59M (-3.23%) | 3.71M (-30.13%) | 5.31M |
Selling General And Administrative | 4.02M (-4.29%) | 4.20M (-30.58%) | 6.05M (+10.20%) | 5.49M (-24.48%) | 7.27M (+12.54%) | 6.46M (+4.19%) | 6.20M (-21.22%) | 7.87M (+33.16%) | 5.91M (+64.17%) | 3.60M (-36.95%) | 5.71M (+113.86%) | 2.67M (-58.60%) | 6.45M |
Operating Expenses | 8.77M (+4.53%) | 8.39M (-18.70%) | 10M (-5.06%) | 11M (-2.95%) | 11M (-26.70%) | 15M (+63.07%) | 9.37M (-26.85%) | 13M (+29.39%) | 9.90M (+17.86%) | 8.40M (-9.68%) | 9.30M (+45.77%) | 6.38M (-45.75%) | 12M |
Depreciation And Amortization | 40K (-66.67%) | 120K | - | - | 40K | -100.00K | 100K (0.00%) | 100K (+150.00%) | 40K | -70.00K | 100K (0.00%) | 100K (+150.00%) | 40K |
Operating Income | |||||||||||||
Operating Income | -8.77M (+4.53%) | -8.39M (-16.18%) | -10.01M (-4.67%) | -10.50M (-6.25%) | -11.20M (-26.70%) | -15.28M (+63.07%) | -9.37M (-26.85%) | -12.81M (+29.39%) | -9.90M (+38.85%) | -7.13M (-21.39%) | -9.07M (+1019.75%) | -810.00K (-92.90%) | -11.41M |
Ebit | -8.77M (+4.53%) | -8.39M (-16.18%) | -10.01M (-4.67%) | -10.50M (-6.25%) | -11.20M (-26.70%) | -15.28M (+63.07%) | -9.37M (-26.85%) | -12.81M (+29.39%) | -9.90M (+38.85%) | -7.13M (-21.39%) | -9.07M (+1019.75%) | -810.00K (-92.90%) | -11.41M |
EBITDA | -8.72M (+21.11%) | -7.20M (+2.86%) | -7.00M (-52.02%) | -14.59M (+30.73%) | -11.16M (-27.39%) | -15.37M (+65.80%) | -9.27M (-27.07%) | -12.71M (+28.90%) | -9.86M (+36.94%) | -7.20M (-19.73%) | -8.97M (+1163.38%) | -710.00K (-93.76%) | -11.37M |
Other Income / Expenses | |||||||||||||
Interest Income | 330K (-21.43%) | 420K (-16.00%) | 500K (-15.25%) | 590K (-10.61%) | 660K (-25.00%) | 880K (-10.20%) | 980K (+75.00%) | 560K (-9.68%) | 620K (-18.42%) | 760K (+10.14%) | 690K (+86.49%) | 370K (+19.35%) | 310K |
Interest Expense | 20K (0.00%) | 20K (-33.33%) | 30K (+50.00%) | 20K (-88.89%) | 180K (-52.63%) | 380K (+8.57%) | 350K (+6.06%) | 330K (+6.45%) | 310K (-11.43%) | 350K (-50.00%) | 700K (-32.04%) | 1.03M (+28.75%) | 800K |
Net Interest Income | 310K (-22.50%) | 400K (-16.67%) | 480K (-14.29%) | 560K (+16.67%) | 480K (-5.88%) | 510K (-19.05%) | 630K (+173.91%) | 230K (-25.81%) | 310K (-24.39%) | 410K | -10.00K (-98.48%) | -660.00K (+34.69%) | -490.00K |
Other Non Operating Income | - | 300K | - | - | - | - | - | - | - | -10.00K | - | - | -10.00K |
Net Income | |||||||||||||
Income Before Tax | -6.72M (-8.57%) | -7.35M (+4.70%) | -7.02M (-51.98%) | -14.62M (+13.42%) | -12.89M (+82.84%) | -7.05M (-53.00%) | -15.00M (+22.45%) | -12.25M (+36.87%) | -8.95M (-7.16%) | -9.64M (+47.63%) | -6.53M (+273.14%) | -1.75M (-85.51%) | -12.08M |
Income Tax Expense | - | - | - | - | - | - | - | - | - | -530.00K | - | - | - |
Net Income From Continuing Operations | -6.72M (-8.57%) | -7.35M (+4.70%) | -7.02M (-51.98%) | -14.62M (+13.42%) | -12.89M (+82.84%) | -7.05M (-53.00%) | -15.00M (+22.45%) | -12.25M (+36.87%) | -8.95M (-1.76%) | -9.11M (+39.51%) | -6.53M (+273.14%) | -1.75M (-85.51%) | -12.08M |
Net Income | -6.72M (-8.57%) | -7.35M (+4.70%) | -7.02M (-51.98%) | -14.62M (+13.42%) | -12.89M (+82.84%) | -7.05M (-53.00%) | -15.00M (+22.45%) | -12.25M (+36.87%) | -8.95M (-1.76%) | -9.11M (+39.51%) | -6.53M (+273.14%) | -1.75M (-85.51%) | -12.08M |
Comprehensive Income Net Of Tax | -8.47M (-74.98%) | -33.85M (+264.37%) | -9.29M (+16.56%) | -7.97M (-14.58%) | -9.33M (-79.09%) | -44.62M (+469.86%) | -7.83M (-36.08%) | -12.25M (+25.64%) | -9.75M (-61.40%) | -25.26M (+149.85%) | -10.11M (+2788.57%) | -350.00K (-96.43%) | -9.80M |